Ceres, Inc. (NASDAQ:CERE), an agricultural biotechnology and seed company, is expanding its current research activities in Mexico. The company’s northern hemisphere plant breeding sites complement its product development activities in Brazil, where the company is commercializing sweet and high-biomass sorghum hybrids for use in renewable fuel and electricity production. Ceres Inc. (NASDAQ:CERE) weekly performance is -10.49%. On last trading day company shares ended up $0.546. Analysts mean target price for the company is $4.00. Ceres Inc. (NASDAQ:CERE) distance from 50-day simple moving average (SMA50) is -35.00%.
Analysts at RBC Capital decreased their target price on shares of Alamos Gold (TSE:AGI) from C$15.00 to C$14.00 in a research report issued to clients and investors on Wednesday, Analyst Ratings.Net reports. The firm currently has an “outperform” rating on the stock. RBC Capital’s target price would suggest a potential upside of 37.12% from the stock’s previous close. Alamos Gold Inc. (NYSE:AGI) shares fell -1.99% in last trading session and ended the day on $8.86. Alamos Gold Inc. (NYSE:AGI) quarterly performance is -2.85%.
Quest Rare Minerals Ltd. (QRM.TO) (NYSEMKT:QRM) is pleased to announce the appointment of Pierre Lortie as a Director of the Company. His experience and background will be of immense benefit to Quest as the company develops its Strange Lake Project. Quest Rare Minerals Ltd Common Shares (Canada) (NYSEMKT:QRM) shares moved down -6.76% in last trading session and was closed at $0.392, while trading in range of $0.39 – $0.42. Quest Rare Minerals Ltd Common Shares (Canada) (NYSEMKT:QRM) year to date (YTD) performance is -16.60%.
Marrone Bio Innovations, Inc. (MBI), (NASDAQ:MBII), a leading global provider of bio-based pest management and plant health products announced its VENERATE™ Bioinsecticide has been submitted for registration in Canada and Mexico. Marrone Bio Innovations Inc. (NASDAQ:MBII) ended the last trading day at $10.40. Company weekly volatility is calculated as 9.88% and price to cash ratio as 5.37.Marrone Bio Innovations Inc. (NASDAQ:MBII) showed a negative weekly performance of -19.69%.